Respiratory & Immunology皇冠登录页面

皇冠注册官网地址

皇冠注册官网地址

皇冠注册官网地址


皇冠注册官网地址

皇冠登录页面




皇冠登录页面


皇冠登录页面


皇冠登录页面


皇冠注册官网地址

Phase III/Reg. refers to assets that are in Phase III or that have been submitted for regulatory approval and may include assets that are now launched in one or more major markets.


皇冠注册官网地址

Phase I

皇冠登录页面

  • AZD0284 psoriasis/respiratory
  • AZD0449 asthma
  • AZD1402 asthma
  • AZD5634 cystic fibrosis
  • AZD8154 asthma
  • MEDI5117 China rheumatoid arthritis

Phase II

皇冠登录页面

  • abediterol asthma/chronic obstructive pulmonary disease
  • anifrolumab lupus nephritis
  • anifrolumab systemic lupus erythematosus (subcutaneous)
  • AZD7986 chronic obstructive pulmonary disease
  • AZD9567 rheumatoid arthritis/respiratory
  • MEDI3506 chronic obstructive pulmonary disease and atopic dermatitis
  • navafenterol (AZD8871) chronic obstructive pulmonary disease
  • tezepelumab atopic dermatitis
  • tezepelumab chronic obstructive pulmonary disease
  • velsecorat (AZD7594) asthma/chronic obstructive pulmonary disease

Phase III

皇冠登录页面

  • anifrolumab TULIP systemic lupus erythematosus
  • Bevespi Aerosphere (PT003) chronic obstructive pulmonary disease
  • Breztri Aerosphere (PT010) chronic obstructive pulmonary disease
  • Fasenra CALIMA SIROCCO ZONDA BISE BORA GREGALE MIRACLE severe uncontrolled asthma
  • nirsevimab passive RSV immunisation
  • PT027 asthma
  • tezepelumab NAVIGATOR SOURCE severe uncontrolled asthma

LCM Projects

皇冠登录页面

  • Breztri (PT010) asthma
  • Duaklir Genuair chronic obstructive pulmonary disease
  • Fasenra MANDARA eosinophilic granulomatosis with polyangiitis
  • Fasenra OSTRO ORCHID (Japan/China) nasal polyposis
  • Fasenra RESOLUTE chronic obstructive pulmonary disease
  • Symbicort SYGMA as-needed use in mild asthma



皇冠登录页面


皇冠注册官网地址

皇冠登录页面


Accolate, Accoleit, Vanticon皇冠登录页面

zafirlukast

Bevespi Aerosphere皇冠登录页面

glycopyrronium/formoterol fumarate

Breztri Aerosphere皇冠登录页面

budesonide/glycopyrronium/formoterol fumarate

Bricanyl Respules皇冠登录页面

terbutaline

Bricanyl Turbuhaler皇冠登录页面

terbutaline in a dry powder inhaler

Daliresp/Daxas皇冠登录页面

roflumilast

Duaklir Genuair皇冠登录页面

aclidinium/formoterol

Eklira Genuair/Tudorza/Bretaris皇冠登录页面

aclidinium, a LAMA

Fasenra皇冠登录页面

benralizumab

Oxis Turbuhaler皇冠登录页面

Oxis Turbuhaler

Pulmicort Respules皇冠登录页面

budesonide inhalation suspension

Pulmicort Turbuhaler皇冠登录页面

budesonide

Rhinocort皇冠登录页面

budesonide

Symbicort pMDI皇冠登录页面

budesonide/formoterol

Symbicort Turbuhaler皇冠登录页面

budesonide/formoterol


皇冠登录页面



Veeva ID: Z4-23796

Date of next review: April 2022